Catapult Capital Management’s AbbVie ABBV Stock Holding History

Catapult Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$1.37M	Sell	25,214 -244,786	-91%	-$15.9M	0.52%	74
2015 Q2	$18.1M	Buy	270,000 +155,000	+135%	+$10.1M	2.61%	4
2015 Q1	$6.73M	Buy	+115,000	New	+$6.95M	0.82%	24
2014 Q4	–	Sell	-100,000	Closed	-$5.78M	–	157
2014 Q3	$5.78M	Hold	100,000	–	–	0.62%	60
2014 Q2	$5.64M	Buy	+100,000	New	+$5.25M	0.63%	39
2013 Q3	–	Sell	-25,000	Closed	-$1.03M	–	236
2013 Q2	$1.03M	Buy	+25,000	New	+$1.09M	0.43%	69

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Catapult Capital Management's ABBV Position: Q3 2015 in Review

Catapult Capital Management reduced its AbbVie (ABBV) stake by 91% in Q3 2015, selling an estimated $15.9M and leaving 25,214 shares worth $1.37M. The position accounts for 0.52% of the portfolio, ranked #74.

Catapult Capital Management first reported a position in ABBV in Q2 2013 and has held it in 6 quarters since. The position peaked at $18.1M in Q2 2015. 1,605 funds tracked by Wall St. Rank hold ABBV as of Q3 2015.

Catapult Capital Management held 25,214 shares of AbbVie worth $1.37M as of Q3 2015.
Catapult Capital Management sold 244,786 AbbVie shares in Q3 2015, an estimated $15.9M.
AbbVie made up 0.52% of Catapult Capital Management's portfolio in Q3 2015, its #74 holding.
Catapult Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 6 quarters since.
Catapult Capital Management's AbbVie position peaked at $18.1M in Q2 2015.
1,605 funds tracked by Wall St. Rank held AbbVie as of Q3 2015.

Based on Catapult Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.